Whole-genome sequencing combined with expression data identifies five LBD loci: three known and two new. Four increased LBD risk while one appears protective.
Based on pooled data from five well-characterized cohorts, women appear to initially outperform men, but then slide faster, on global cognition and executive function. Oddly, this was not true for memory.
The commercial test uses a few drops of saliva. It must be ordered by a physician. Plans are also in the works to use the test to select participants for clinical trials.
Epidemiology study reveals 1.5-times higher risk of dementia after herpes virus infection. Short-term antiviral treatment appears to lower risk.
Researchers split $200,000 for their theories on the role of six microbes—one virus, four bacteria, and one parasite—in Alzheimer’s.
In mice, an anti-ApoE antibody removed plaques from the brain’s parenchyma and blood vessels better than aducanumab. Importantly, it caused no microhemorrhages.
Van Leeuwen was best known for finding frameshift mutations in APP and ubiquitin B in the brains of people with tauopathies.
Researchers unearthed 75 risk loci, 42 of them new, and nominated candidate genes for each. A polygenic risk score based on all variants predicted AD risk with high accuracy.
Virtual Exhibit Hall
Alzforum encourages users to visit the Virtual Exhibit Hall, where companies showcase their newest initiatives, products, and services. We welcome F. Hoffmann-La Roche, joining our other exhibitors — Biogen, BioLegend, Abcam, BrainXell, and the Jackson Laboratory.
Genetics place Lewy body dementia in between Parkinson’s and Alzheimer’s. Whole-genome sequencing and GWAS, backed by expression data, identified five LBD loci. GBA, APOE, and SNCA were previously known as LBD genes; BIN1 and TMEM175 are new to this mixed disease. An SNCA variant protects, the others increase LBD risk. Three are known PD genes, two are AD genes.
Scientists disagree about whether women face a greater risk of cognitive decline than men. In a new study, researchers who pooled data from five established longitudinal cohorts that track cognition report that, among 26,000 people, global cognition and executive function declined faster in women than men. Memory slipped at the same pace in both sexes. Curiously, women outperformed men in all three categories, indicating they enjoy more cognitive reserve. The sex differences remained after correcting for some other factors that affect cognition, including cardiovascular risk factors and education level.
Due to—you guessed it—a certain virus, the International Conference on Alzheimer’s and Parkinson’s Diseases will have to unfold virtually once more, until more of the world is vaccinated. The 15th installment of this six-day long annual meeting will start on March 9. It costs between €300 and €500; for that, three pre-conferences are included, and recorded presentations will stay accessible for three months after the meeting ends on the 14th. Added bonus: no jet lag, no mask, no more “Can’t believe I missed that talk! I was in a different session.” This time, you can see and hear it all. Register here.
Antibodies such as aducanumab clear amyloid plaque from the brain, but they also cause tiny tears in cerebral blood vessels that cause ARIA. Is there a safer way? In mice, antibodies directed against ApoE, a component of dense-core plaques, mopped up deposits in brain and blood vessels more effectively than did aducanumab. Importantly, this therapy caused no microhemorrhages. The data hint that antibodies targeting ApoE could be safer for long-term therapy.
Want more Alzheimer’s genes? A new GWAS meta-analysis has you covered, turning up 42 new loci linked to the disease. Leading candidate genes participate in amyloid and tau metabolism, endocytosis, and immunity, highlighting the importance of these processes in disease pathogenesis. Piled into a polygenic risk score, they predict risk of dementia in healthy controls with 84 percent accuracy. A second study maps DNA to identify functional genes at many AD loci. Get the lowdown in Madolyn Rogers’ story.
- Richard Lathe on Alzheimer’s Field Loses Fred van Leeuwen, 71
- Ruth Itzhaki on Herpes Update—Virus Increases Dementia Risk in Sweden
- William Eimer and Rudy Tanzi on Herpes Update—Virus Increases Dementia Risk in Sweden
- Christian Schnier and Janet Janbek on Herpes Update—Virus Increases Dementia Risk in Sweden
- J.P.H. Burbach on Alzheimer’s Field Loses Fred van Leeuwen, 71
- Davangere Devanand on Herpes Update—Virus Increases Dementia Risk in Sweden
- Nico Dantuma on Alzheimer’s Field Loses Fred van Leeuwen, 71
- Marcus O. W. Grimm and Tobias Hartmann on Alzheimer’s Field Loses Fred van Leeuwen, 71
- Daniel Michaelson on Would ApoE Make a Better Therapeutic Target Than Aβ?
- Shea Andrews on Massive GWAS Meta-Analysis Digs Up Trove of Alzheimer’s Genes
- Cristian Lasagna-Reeves on Would ApoE Make a Better Therapeutic Target Than Aβ?
- Gary Landreth on Would ApoE Make a Better Therapeutic Target Than Aβ?
- Richard Mayeux on Massive GWAS Meta-Analysis Digs Up Trove of Alzheimer’s Genes
- Carlos Cruchaga on Massive GWAS Meta-Analysis Digs Up Trove of Alzheimer’s Genes
- Nancy Ip on Massive GWAS Meta-Analysis Digs Up Trove of Alzheimer’s Genes
- John Hardy on Massive GWAS Meta-Analysis Digs Up Trove of Alzheimer’s Genes
- Yun Chen and Marco Colonna on Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease.
- Leslie Norins on Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer’s
- Charles Stromeyer on APOE Tied to Increased Susceptibility to SARS-CoV-2
- Mathias Toft on TWAS x GWAS? Transcriptome Analysis Finds 11 Parkinson’s Genes
- Eric M. Reiman on Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer’s